Epstein barr virus hemophagocytic lymphohistiocytosis related to rituximab use and immunopathogenetic insights. [electronic resource]
Producer: 20170519Description: 1194-1198 p. digitalISSN:- 1618-0631
- Aged
- Antineoplastic Agents -- adverse effects
- Epstein-Barr Virus Infections -- drug therapy
- Hodgkin Disease -- drug therapy
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Lymphohistiocytosis, Hemophagocytic -- complications
- Male
- Neoplasms, Second Primary -- drug therapy
- Rituximab -- adverse effects
- Virus Activation
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.